Selective effects of pioglitazone on insulin and androgen abnormalities in normo‐ and hyperinsulinaemic obese patients with polycystic ovary syndrome

By Romualdi D.   Guido M.   Ciampelli M.   Giuliani M.   Leoni F.   Perri C.   Lanzone A.  

Human Reproduction, Vol. 18, Iss. 6, 2003-06 ,pp. : 1210-1218

Oxford University Press

Access to resources Recommend Favorite

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.

By Buyalos R P   Geffner M E   Azziz R   Judd H L  

Human Reproduction, Vol. 12, Iss. 6, 1997-06 ,pp. : 1138-1141

Oxford University Press

Access to resources Recommend Favorite

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

By Yilmaz Murat   Bi˙ri˙ Aydan   Bukan Neslihan   Karakoç Ayhan   Sancak Banu   Törüner Füsun   Paşaoğlu Hatice  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 258-263

Informa Healthcare

Access to resources Recommend Favorite

Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome

By Takeuchi Toru   Tsutsumi Osamu   Taketani Yuji  

Gynecological Endocrinology, Vol. 24, Iss. 7, 2008-01 ,pp. : 385-391

Informa Healthcare

Access to resources Recommend Favorite